Method and apparatus for dynamically monitoring, detecting and diagnosing lead conditions

• US 7,515,961 B2
• Filed: 04/29/2005
• Issued: 04/07/2009
• Est. Priority Date: 04/29/2005
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Germanson, Nancy M., Braly, Alan R., Spear, Thomas H., McVenes, Rick D.
• Primary Examiner(s): Layno; Carl H.
• Assistant Examiner(s): LEE, YUN HAENG NMN
• Application Number:
  US11/119,529
• Publication Number:
  US 20060247706A1
• Time in Patent Office: 1,439 Days
• Field of Search: 607 27- 28, 600/547
• US Class Current: 607/27
• CPC Class Codes: A61N 1/3706 Pacemaker parameters stimulation threshold A61N1/371
• CPC Class Codes: A61N 1/37258 Alerting the patient
• CPC Class Codes: A61N 2001/083 Monitoring integrity of contacts, e.g. by impedance measurement

Abstract

The present invention provides diverse methods and apparatus for in vivo monitoring, detecting and/or predicting potential failure modes or deleterious trends of chronically implanted medical electrical leads prior to actual failure of said leads. Certain embodiments of the invention involve applying a relatively increased data sampling rate at various time intervals (e.g., periodically, randomly, and/or manually-triggered and the like) prior to actual detection of a deleterious trend, to thereby increase the probability of detecting one or more parameters indicative of a potential lead performance issue. At least some of the parameters are utilized because they are not typically reliably detected at relatively lower data sampling rates. In addition to an initial relatively increased data sampling rate, certain embodiments provide for adjusting the sampling rate and storing and/or adjusting data pattern template-based data to execute pattern related triggers so that additional information regarding a medical electrical lead can be obtained.

Claims

1. A method for detecting a lead-related condition, comprising:

collecting a first set of data of a plurality of medical electrical lead surveillance parameters at a first data sampling rate from an active implantable medical device (IMD) implanted in a subject;

concurrently comparing the collected plurality of surveillance parameters to a baseline template and evaluating any deviation, wherein the baseline template is a digitized representation of data patterns or sequences of lead-related data, wherein said baseline template includes a similar plurality of medical electrical lead surveillance parameters from the active IMD implanted in the subject; and

deriving an indication of lead failure from the deviation.

2. A method according to claim 1, wherein if the deviation is greater than a first threshold then:

evaluating template adjustment criteria, wherein the template adjustment criteria include additional surveillance parameter data;

replacing the baseline template with an adjusted baseline template if the template adjustment criteria are met.

3. A method according to claim 2, further comprising comparing the plurality of surveillance parameters collected with lead surveillance criteria if the adjustment criteria are not met, wherein the lead surveillance criteria include templates of at least one of:

representations of degraded lead characteristics, defective lead characteristics.

4. A method according to claim 2, wherein the adjustment criteria include analyzing additional surveillance parameter data.

5. A method according to claim4, wherein the additional surveillance parameter data include at least one of:

a wave morphology metric, a slew metric, a sense/pace counter metric, a short-circuit pace event metric, an open circuit pace metric, a non-physiologic sense metric, a premature ventricular contraction (PVC) metric, a loss of capture metric, a capture interval metric, a capture duration metric, a heart wall acceleration metric, an activity sensor data metric, a heart rate metric, a blood pressure metric, a stress metric, a strain metric, an oxygen saturation metric, an enzyme activity metric.

6. A method according to claim 1, wherein the IMD comprises:

a pacemaker, an implantable cardioverter-defibrillator, a neurological stimulation device, a deep brain stimulation device, a muscle stimulation device, an implantable pulse generator, an active medical device coupled to at least one elongated medical electrical lead.

7. A method according to claim 1, further comprising:

storing one of the collected parameters and the results of the compared parameters in a memory structure.

8. A method according to claim 1, further comprising telemetering a status notification of the deviation.

9. A method according to claim 1, wherein the baseline template is created by:

selecting default programmable surveillance parameters;

inputting values for the default programmable surveillance parameters; and

creating the baseline template from the values for the default programmable surveillance parameters for a particular data collection interval.

10. An apparatus for detecting a lead-related condition, comprising:

means for collecting a first set of data of a plurality of medical electrical lead surveillance parameters from an active implantable medical device (IMD) implanted in a subject;

means for concurrently comparing the collected plurality of lead surveillance parameters to a baseline template to evaluate any deviation, wherein the baseline template is a digitized representation of data patterns or sequences of lead-related data, wherein said baseline template includes a similar plurality of medical electrical lead surveillance parameters from the active IMD implanted in the subject; and

means for determining whether the deviation is indicative of lead failure.

11. An apparatus according to claim 10, wherein if the deviation is greater than a first threshold value further comprising:

means for comparing template adjustment criteria to the plurality of surveillance parameters collected; and

means for replacing the baseline template with an adjusted baseline template.

12. An apparatus according to claim 11, further comprising means for comparing the collected plurality of surveillance parameters with lead surveillance criteria if the adjustment criteria are not met, wherein the lead surveillance criteria include templates of at least one of:

representations of degraded lead characteristics, defective lead characteristics.

13. An apparatus according to claim 11, wherein the adjustment criteria include analyzing additional surveillance parameter data.

14. An apparatus according to claim 13, wherein the additional surveillance parameter data include at least one of:

a wave morphology metric, a slew metric, a sense/pace counter metric, a short-circuit pace event metric, an open circuit pace metric, a non-physiologic sense metric, a premature ventricular contraction (PVC) metric, a loss of capture metric, a capture interval metric, a capture duration metric, a heart wall acceleration metric, an activity sensor data metric, a heart rate metric, a blood pressure metric, a stress metric, a strain metric, an oxygen saturation metric, an enzyme activity metric.

15. A method for detecting a lead related condition comprising:

defining a plurality of medical electrical lead surveillance parameters;

defining a first sampling rate for each of the plurality of surveillance parameters, wherein each of the sampling rates is independent of the other sampling rates;

creating a patient specific baseline template, wherein the baseline template is a digitized representation of data patterns or sequences of lead-related data, wherein the method of creating the template comprises;

collecting a first set of data of the plurality of surveillance parameters at the defined sampling rates; and

generating a patient specific template based on the first set of data;

diagnosing the lead related condition, wherein the method of diagnosing comprises;

collecting a second set of data of the plurality of surveillance parameters at the defined sampling rates; and

concurrently comparing the second set of data to the baseline template to evaluate any deviation; and

determining whether the deviation is indicative of lead failure.

16. A method according to claim 15, further comprising telemetrically communicating a status notification based on the deviation.

17. A method according to claim 15, further comprising evaluating template adjustment criteria if the deviation is greater than a first threshold value, wherein the template adjustment criteria includes data from at least one of:

an accelerometer, an oxygen sensor.

18. A method according to claim 17, further comprising adjusting the patient specific baseline template with the collected surveillance parameters if the template adjustment criteria are met.

19. A method according to claim 15,wherein the step of determining whether the deviation is indicative of lead failure includes:

selecting one or more of the plurality of surveillance parameters;

defining a second sampling rate for each of the plurality of surveillance parameters, wherein the second sampling rate is greater than the first sampling rate;

collecting a third set of data of one or more of the selected plurality of surveillance parameters at the second sampling rate; and

comparing the third set of data to lead surveillance criteria, wherein the lead surveillance criteria include templates of at least one of;

representations of degraded lead characteristics, defective lead characteristics.

20. A method according to claim 15, wherein the surveillance parameter data include at least one of:

impedance, threshold, pressure.